Aug. 26 at 6:49 PM
$NUVB rally will continue imho, even though road will be bumpy. # bullish
$TNXP Ok..another bad day...but..I think a lot of people are underestimating the potential here. Let me be clear from the start: always keep your portfolio diversified. No matter how promising something looks, never go all-in, even if it feels like your once-in-a-lifetime shot. That said, it’s worth taking a step back and looking at this situation objectively.
The fibromyalgia market is massive, and it continues to expand. For a drug to be a success here, it doesn’t need to capture half the market..just 10% would already represent a major opportunity. This candidate has repeatedly shown excellent results across multiple trials, and what stands out is that it achieved this with a relatively straightforward approach. That positions it as a potential best-in-class therapy, or at the very least a strong contender with clear advantages over leading competitors.
PART II BELOW!
